Annex XV Report

Annex XV Report

Annex XV report PROPOSAL FOR IDENTIFICATION OF A SUBSTANCE OF VERY HIGH CONCERN ON THE BASIS OF THE CRITERIA SET OUT IN REACH ARTICLE 57 Substance Name(s): 1,6,7,8,9,14,15,16,17,17,18,18- Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”TM) [covering any of its individual anti- and syn-isomers or any combination thereof] EC Number(s): 236-948-9; -; - CAS Number(s): 13560-89-9; 135821-74-8; 135821-03-3 Submitted by: United Kingdom Date: 29 August 2017 ANNEX XV – IDENTIFICATION OF DECHLORANE PLUS AS SVHC CONTENTS PROPOSAL FOR IDENTIFICATION OF A SUBSTANCE OF VERY HIGH CONCERN ON THE BASIS OF THE CRITERIA SET OUT IN REACH ARTICLE 57..........................................................................................IV PART I ...............................................................................................................................................1 JUSTIFICATION ..................................................................................................................................1 1. IDENTITY OF THE SUBSTANCE AND PHYSICAL AND CHEMICAL PROPERTIES ...................................2 1.1 Name and other identifiers of the substance................................................................................2 1.2 Composition of the substance ........................................................................................................2 1.3 Identity and composition of degradation products/metabolites relevant for the SVHC assessment ....................................................................................................................................3 1.4 Identity and composition of structurally related substances (used in a benchmarking or read- across approach) ...........................................................................................................................7 1.5 Physicochemical properties ..........................................................................................................12 2. HARMONISED CLASSIFICATION AND LABELLING..........................................................................16 3. ENVIRONMENTAL FATE PROPERTIES ...........................................................................................17 3.1 Degradation ..................................................................................................................................17 3.1.1 Abiotic degradation ...............................................................................................................17 3.1.2 Biodegradation ......................................................................................................................18 3.1.3 Other data..............................................................................................................................23 3.1.4 Summary and discussion of degradation...............................................................................23 3.2 Environmental distribution ...........................................................................................................24 3.2.1 Adsorption/desorption...........................................................................................................24 3.2.2 Volatilisation..........................................................................................................................24 3.2.3 Distribution modelling ...........................................................................................................25 3.3 Data indicating potential for long-range transport.......................................................................26 3.4 Bioaccumulation ...........................................................................................................................30 3.4.1 Bioaccumulation in aquatic organisms (pelagic & sediment organisms) ..............................30 3.4.2 Bioaccumulation in terrestrial organisms (soil dwelling organisms, vertebrates) .................44 3.4.4 Summary and discussion of bioaccumulation........................................................................52 4. HUMAN HEALTH HAZARD ASSESSMENT ......................................................................................55 4.1 Toxicokinetics (absorption, metabolism, distribution and elimination) .......................................55 5. ENVIRONMENTAL HAZARD ASSESSMENT ....................................................................................57 6. CONCLUSIONS ON THE SVHC PROPERTIES ...................................................................................58 6.1 CMR assessment ...........................................................................................................................58 6.2 PBT and vPvB assessment.............................................................................................................58 6.2.1 Assessment of PBT/vPvB properties.......................................................................................58 6.2.1.3.1 Fulfilment of the T criterion based on human health classification .................................63 6.2.1.3.2 Fulfilment of the T criterion based on ecotoxicity data ................................................63 6.2.2 Summary and overall conclusions on the PBT and vPvB properties.......................................65 PART II ............................................................................................................................................67 7. REGISTRATION AND C&L NOTIFICATION STATUS .........................................................................67 7.1 Registration status.......................................................................................................................67 7.2 CLP notification status ..................................................................................................................67 8. TOTAL TONNAGE OF THE SUBSTANCE..........................................................................................67 i ANNEX XV – IDENTIFICATION OF DECHLORANE PLUS AS SVHC 9. INFORMATION ON USES OF THE SUBSTANCE...............................................................................68 Quantities ...........................................................................................................................................71 10. INFORMATION ON STRUCTURE OF THE SUPPLY CHAIN..............................................................73 11. ADDITIONAL INFORMATION......................................................................................................73 11.1 Substances with similar hazard and use profiles on the Candidate List .....................................73 11.2 Alternatives.................................................................................................................................73 11.3 Existing EU legislation .................................................................................................................73 11.4 Previous assessments by other authorities ................................................................................73 REFERENCES FOR MAIN REPORT AND APPENDICES .........................................................................75 LIST OF APPENDICES........................................................................................................................90 ii ANNEX XV – IDENTIFICATION OF DECHLORANE PLUS AS SVHC TABLES Table 1: Substance identity of 1,6,7,8,9,14,15,16,17,17,18,18- dodecachloropentacyclo-[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene, Dechlorane Plus [1]. ....................................................................................................2 Table 2: Substance identity of (1S,2S,5S,6S,9R,10R,13R,14R)- 1,6,7,8,9,14,15,16,17,17,18,18- dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene, anti- (or exo ) Dechlorane Plus [2, see structural formula below].........................................3 Table 3: Substance identity of (1S,2S,5R,6R,9S,10S,13R,14R)- 1,6,7,8,9,14,15,16,17,17,18,18- dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene, syn- (or endo ) Dechlorane Plus [3, , see structural formula below] .......................................4 Table 4: Constituents other than impurities/additives ......................................2 Table 5: Identity of 1,3-DPMA ......................................................................4 Table 6: Identity of 1,5-DPMA ......................................................................5 Table 7: Identity of DP-1Cl...........................................................................6 Table 8: Identity of DP-2Cl...........................................................................6 Table 9: Identity of selected analogues..........................................................8 Table 10: Overview of physicochemical properties .........................................12 Table 11: Summary of predicted and measured degradation data for Dechlorane Plus analogues..........................................................................................21 Table 12: Input properties used in assessing long range transport potential....28 Table 13: Depuration half-lives and BCF values for chemicals meeting the vB criteria ....................................................................................................39 Table 14: Registration status ......................................................................67 Table 15: CLP notifications .........................................................................67

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    99 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us